Showing results (181-190 of 197) with videos related to
Sort By:
Pageof 20
Nature Medicine|July 8, 1999
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivoJ S Sebolt-Leopold, D T Dudley, R Herrera, et al.Nature Communications|November 8, 2019
Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysisJethro S Johnson, Daniel J Spakowicz, Bo-Young Hong, et al.Mbio|April 26, 2018
Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in Escherichia coliLisa M Schechter, David P Creely, Cherilyn D Garner, et al.Cancer Research|May 3, 2006
Dynamic imaging of emerging resistance during cancer therapyKuei C Lee, Daniel E Hall, Benjamin A Hoff, et al.Journal of Neuropsychology|February 9, 2020
Left posterior prefrontal regions support domain-general executive processes needed for both reading and mathKai Wang, Marie T Banich, Andrew E Reineberg, et al.Developmental Cognitive Neuroscience|May 7, 2019
Characterizing and decomposing the neural correlates of individual differences in reading ability among adolescents with task-based fMRIKai Wang, Daniel R Leopold, Marie T Banich, et al.Journal of the American Academy of Child and Adolescent Psychiatry|August 25, 2022
Report of a Work Group on Sluggish Cognitive Tempo: Key Research Directions and a Consensus Change in Terminology to Cognitive Disengagement SyndromeStephen P Becker, Erik G Willcutt, Daniel R Leopold, et al.Proceedings of the National Academy of Sciences of the United States of America|May 15, 2009
A precise reconstruction of the emergence and constrained radiations of Escherichia coli O157 portrayed by backbone concatenomic analysisShana R Leopold, Vincent Magrini, Nicholas J Holt, et al.Nature|June 3, 2026
Commensal-derived acetylcholine enhances mucosal immune educationDeguang Song, Brianna Duncan-Lowey, Varnica Khetrapal, et al.Proceedings of the National Academy of Sciences of the United States of America|September 30, 1998
Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitorD W Fry, A J Bridges, W A Denny, et al.Pageof 20